Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 27 October 2017

Indication(s)

Treatment of essential hypertension.
This fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Type 2 Diabetes

Type 2 Diabetes

View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more.

Obesity

Obesity

Learn about the complex factors influencing development of obesity.

+ 4 more

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/002302
Orphan designation No
Date First Approved 04-03-2011
Type Medicinal product subject to medical prescription
Marketing authorisation holder Krka, d.d., Novo mesto